TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.62
+0.12 (2.18%)
Mar 28, 2025, 4:00 PM EDT - Market closed
TriSalus Life Sciences Employees
TriSalus Life Sciences had 112 employees as of December 31, 2023. The number of employees increased by 37 or 49.33% compared to the previous year.
Employees
112
Change (1Y)
37
Growth (1Y)
49.33%
Revenue / Employee
$262,777
Profits / Employee
-$296,723
Market Cap
175.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 112 | 37 | 49.33% |
| Dec 31, 2022 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TLSI News
- 19 hours ago - TriSalus Life Sciences: Optimistic Guidance For 2025, But There Are Still Risks - Seeking Alpha
- 3 days ago - TriSalus Life Sciences, Inc. (TLSI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 days ago - TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update - Business Wire
- 4 days ago - TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping - Business Wire
- 24 days ago - TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model” - Business Wire
- 7 weeks ago - TriSalus Life Sciences Announces Key Appointments to Board of Directors - Business Wire
- 7 weeks ago - TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed - Business Wire
- 2 months ago - TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call - Business Wire